Payments
Forms
About Us
News
Contact Us
Home
Our Test
Parents
Providers
Payments
Forms
About Us
News
Contact Us
Legal
Search for:
Home
Our Test
Parents
Providers
Payments
Forms
About Us
News
Contact Us
Legal
News
NeuroPointDX Names E. Robert Wassman, M.D. as Medical Director
Read More
NeuroPointDX Announces Commercialization of First Objective Blood Test to Aid Earlier Diagnosis of Autism Spectrum Disorder
Read More
NeuroPointDX Appoints Noted Neurodevelopmental Expert, Marvin Natowicz, M.D., Ph.D. to Its Scientific Advisory Board
Read More
Earlier Autism Diagnosis Possible for Some Children Based on Metabolic Biomarkers in Blood, New Research Shows
Read More
NeuroPointDX Announces Confirmation of First-Generation Autism Diagnostic Panel
Read More
Stemina Featured as an Innovative Madison-Area Business
Read More
Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics
Read More
NeuroPointDX Presented Poster at IMFAR 2017: Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP)
Read More
Metabolic Profiling of the Children’s Autism Metabolome Project (CAMP) – IMFAR 2017 [PDF]
Read More
NeuroPointDX Partners with Ovid Therapeutics to Identify Biomarkers for Angelman Syndrome
Read More
Page 1 of 2
1
2
»
RT
@AtlanticLab
: Using mass spectrometry to look at metabolic subtypes for autism spectrum disorder. Recently completed largest metabolomic…
2 days ago
Speaker, author, and autism advocate Temple Grandin urged audiences at Vanderbilt University to embrace neurodivers…
https://t.co/iomuQFXV2n
2 days ago
Metabolomics is the study of small molecules, called metabolites, found in our cells, fluids, or tissues; it is the…
https://t.co/SN8tBNTrBh
2 days ago
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Accept
Read More
